Endogena Therapeutics
Endogena’s mission is to discover and develop first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs.
Org chart
Matthias Steger
CEO & Co-Founder
Collapse
Moreno Menghini
Chief Medical Officer
Daphna Mokady
VP, Discovery Biology
Sven Weiler
VP, Medicinal Chemistry
Susanne Raab
Head, Vivo Pharmacology
Manfred Schneider
Head, Toxicology
Marco Randazzo
Head, AI & Cheminformatics
Arturo Ortin-Martinez
Senior Scientist
Christiane Hyvert
People & Culture Business Partner, Operations Manager
Christiane Hyvert
People & Culture, Operations
Teams
View all
Discover similar companies
Gameto
Series A • New York, United States
Neogene Therapeutics
Series A • New York, United States
X-Vax Technology
Series A • Jupiter, United States
Chroma Medicine
Series A • Cambridge, United States
CytoKi Pharma
Series A • Værløse, Denmark
Theolytics
Series A • Oxford, United Kingdom
Xontogeny
Series A • Boston, United States
Primmune Therapeutics
Series A • San Diego, United States
Charm Therapeutics
Series A • London, United Kingdom
Sano Genetics
Series A • England, United Kingdom
Polyneuron Pharmaceuticals
Series A • Basel, Switzerland
Kula Bio
Series A • Somerville, United States
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.